STEM-Talk cover image

Episode 132: Martin Kulldorff discusses vaccines, lockdowns, school closings and the global response to COVID-19

STEM-Talk

00:00

Drug Safety and Risk Management Advisory Committee

Since a 20 18, you've been a member of the f d a's drug safety and risk management advisory committee. Can you talk a little bit about this work and how it interacts with the agency? "It is the way to help the fda, to get outside independent views on whether a specific drug should be approved or not"

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app